GB9804121D0 - Anti-angiogenic vaccines: materials and methods relating thereto - Google Patents

Anti-angiogenic vaccines: materials and methods relating thereto

Info

Publication number: GB9804121D0
Authority: GB; United Kingdom
Prior art keywords: angiogenic; vaccines; materials; methods relating; relating
Prior art date: 1998-02-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9804121.3A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cancer Research Campaign Technology Ltd

Original Assignee

Cancer Research Campaign Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-26

Filing date

1998-02-26

Publication date

1998-04-22

1998-02-26 Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd

1998-02-26 Priority to GBGB9804121.3A priority Critical patent/GB9804121D0/en

1998-04-22 Publication of GB9804121D0 publication Critical patent/GB9804121D0/en

1999-02-26 Priority to AU26331/99A priority patent/AU2633199A/en

1999-02-26 Priority to EP99906368A priority patent/EP1056852A1/en

1999-02-26 Priority to PCT/GB1999/000583 priority patent/WO1999043801A1/en

Status Ceased legal-status Critical Current

Links

230000001772 anti-angiogenic effect Effects 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Immunology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

GBGB9804121.3A 1998-02-26 1998-02-26 Anti-angiogenic vaccines: materials and methods relating thereto Ceased GB9804121D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GBGB9804121.3A GB9804121D0 (en)	1998-02-26	1998-02-26	Anti-angiogenic vaccines: materials and methods relating thereto
AU26331/99A AU2633199A (en)	1998-02-26	1999-02-26	Anti-angiogenic vaccines: substances and methods relating thereto
EP99906368A EP1056852A1 (en)	1998-02-26	1999-02-26	Anti-angiogenic vaccines: substances and methods relating thereto
PCT/GB1999/000583 WO1999043801A1 (en)	1998-02-26	1999-02-26	Anti-angiogenic vaccines: substances and methods relating thereto

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9804121.3A GB9804121D0 (en)	1998-02-26	1998-02-26	Anti-angiogenic vaccines: materials and methods relating thereto

Publications (1)

Publication Number	Publication Date
GB9804121D0 true GB9804121D0 (en)	1998-04-22

Family

ID=10827659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9804121.3A Ceased GB9804121D0 (en)	1998-02-26	1998-02-26	Anti-angiogenic vaccines: materials and methods relating thereto

Country Status (4)

Country	Link
EP (1)	EP1056852A1 (en)
AU (1)	AU2633199A (en)
GB (1)	GB9804121D0 (en)
WO (1)	WO1999043801A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6521424B2 (en)	1999-06-07	2003-02-18	Immunex Corporation	Recombinant expression of Tek antagonists
DE60133743T2 (en)	2000-08-21	2009-07-02	Pacific Corp.	NEW THIOUREA DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU2002247304A1 (en)	2001-03-07	2002-09-19	Mannkind Corporation	Anti-neovasculature preparations for cancer
US7138370B2 (en)	2001-10-11	2006-11-21	Amgen Inc.	Specific binding agents of human angiopoietin-2
US7521053B2 (en)	2001-10-11	2009-04-21	Amgen Inc.	Angiopoietin-2 specific binding agents
US7205275B2 (en)	2001-10-11	2007-04-17	Amgen Inc.	Methods of treatment using specific binding agents of human angiopoietin-2
US7658924B2 (en)	2001-10-11	2010-02-09	Amgen Inc.	Angiopoietin-2 specific binding agents
DK2261249T3 (en) *	2002-09-12	2015-02-16	Oncotherapy Science Inc	KDR peptides and vaccines comprising the same
CA2529056C (en)	2003-06-17	2013-09-10	Mannkind Corporation	Combinations of tumor-associated antigens in compositions for various types of cancers
WO2006071983A2 (en)	2004-12-29	2006-07-06	Mannkind Corporation	Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
TWI436775B (en)	2007-08-24	2014-05-11	Oncotherapy Science Inc	Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
JO2913B1 (en)	2008-02-20	2015-09-15	امجين إنك,	Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
TW201109029A (en)	2009-06-11	2011-03-16	Oncotherapy Science Inc	Vaccine therapy for choroidal neovascularization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994000469A1 (en) *	1992-06-26	1994-01-06	Immunex Corporation	Novel tyrosine kinase
US5681714A (en) *	1992-07-30	1997-10-28	Mount Sinai Hospital Corporation	Nucleic acid encoding tek receptor tyrosine kinase
WO1995013387A1 (en) *	1993-11-12	1995-05-18	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Tie-2, a novel receptor tyrosine kinase
AUPM379494A0 (en) *	1994-02-10	1994-03-03	Ludwig Institute For Cancer Research	Immunointeractive molecules - ii
WO1997041440A1 (en) *	1996-04-26	1997-11-06	Rijksuniversiteit Te Leiden	Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes

1998
- 1998-02-26 GB GBGB9804121.3A patent/GB9804121D0/en not_active Ceased
1999
- 1999-02-26 AU AU26331/99A patent/AU2633199A/en not_active Abandoned
- 1999-02-26 WO PCT/GB1999/000583 patent/WO1999043801A1/en not_active Application Discontinuation
- 1999-02-26 EP EP99906368A patent/EP1056852A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1056852A1 (en)	2000-12-06
WO1999043801A1 (en)	1999-09-02
AU2633199A (en)	1999-09-15

Legal Events

Date	Code	Title	Description
1999-05-19	AT	Applications terminated before publication under section 16(1)

Publication	Publication Date	Title
EP1176948A4 (en)	2007-06-20	Anti-nausea compositions and methods
CZ20011341A3 (en)	2001-09-12	Auxiliary preparations and vaccines
EP1223932A4 (en)	2003-01-15	Compounds and methods
EP1146790A4 (en)	2004-03-17	Compounds and methods
GB9812613D0 (en)	1998-08-12	Vaccine
EP1313477A4 (en)	2004-03-03	Compounds and methods
AU6832101A (en)	2001-12-24	Composition and method
EP1274424A4 (en)	2003-09-17	Compounds and methods
HUP0202537A3 (en)	2004-05-28	A vaccine composition and method of using the same
AU4163402A (en)	2002-06-18	Composition and method
IL140239A0 (en)	2002-02-10	Anti-angiogenic proteins and methods of use thereof
GB9804121D0 (en)	1998-04-22	Anti-angiogenic vaccines: materials and methods relating thereto
HUP0103473A3 (en)	2003-01-28	Phosphoglycolipid and methods for its use
GB9822714D0 (en)	1998-12-09	Vaccines
GB0020363D0 (en)	2000-10-04	Detector asssemblies and methods
EP1343796A4 (en)	2005-01-12	Compounds and methods
ZA982763B (en)	1998-10-05	Vaccines
GB9805630D0 (en)	1998-05-13	Improvements in creamic materials
HK1042016A1 (en)	2002-08-02	Insectidal mat and heat-transpiration insectidal method using the same
EP1272512A4 (en)	2003-05-07	Immunokine composition and method
GB0017184D0 (en)	2000-08-30	Container assembly and container unit
GB0020137D0 (en)	2000-10-04	Material and method
GB0013603D0 (en)	2000-07-26	Material and method
GB9826121D0 (en)	1999-01-20	Products and methods
GB0021922D0 (en)	2000-10-25	Edging-slabs and methods using them